Lethal Effect of the Intravenous Injection of H-2 Alloantigen Activated T Cells

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1982 Dec 1

PMID 6984670

Citations 1

Authors

L Andrus

K Atkinson

K J Lafferty

Affiliations

Soon will be listed here.

Abstract

T cells of C57BL/6J (B6) mice activated in vitro against the K and D determinants of the H-2d haplotype, and expanded in tissue culture in the presence of interleukin 2, were capable of rapidly killing lethally irradiated BALB/c recipients when injected intravenously. Mice given 10(6), 10(7) and 10(8) such T cells survived 10.5, 8.5 and 0.5 days respectively. Mice given irradiation only survived 10.5 days. Mice given 10(8) B6 T cells activated against all determinants of a third party haplotype (H-2k) survived 8.5 days. Respiratory distress developed within 3 hr of injection in mice given 10(8) T cells activated against the H-2 alloantigens of the recipient haplotype, and at autopsy their lungs showed pulmonary congestion, focal obliteration of the alveolar space and thickening of alveolar interstitial tissue with fibrin, red cell and a mononuclear cell infiltrate. These findings may have relevance to the use of cellular immunotherapy.

Citing Articles

Acute lethal graft-versus-host reaction induced by major histocompatibility complex class II-reactive T helper cell clones.

Lehmann P, Schumm G, Moon D, Hurtenbach U, Falcioni F, Muller S J Exp Med. 1990; 171(5):1485-96.

PMID: 2139696 PMC: 2187885. DOI: 10.1084/jem.171.5.1485.

References

Woolnough J, Lafferty K . Generation of homogeneous populations of alloreactive T cells in vitro. Aust J Exp Biol Med Sci. 1979; 57(2):127-39. DOI: 10.1038/icb.1979.13. View

Watson J, Gillis S, Marbrook J, Mochizuki D, Smith K . Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med. 1979; 150(4):849-61. PMC: 2185677. DOI: 10.1084/jem.150.4.849. View

Mills G, Carlson G, Paetkau V . Generation of cytotoxic lymphocytes to syngeneic tumors by using co-stimulator (Interleukin 2): in vivo activity. J Immunol. 1980; 125(5):1904-9. View

Geczy C, Hopper K . A mechanism of migration inhibition in delayed-type hypersensitivity reactions. II. Lymphokines promote procoagulant activity of macrophages in vitro. J Immunol. 1981; 126(3):1059-65. View

Cheever M, Greenberg P, Fefer A . Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2. J Immunol. 1981; 126(4):1318-22. View

Parr E . The absence of H-2 antigens from mouse pancreatic beta-cells demonstrated by immunoferritin labeling. J Exp Med. 1979; 150(1):1-9. PMC: 2185614. DOI: 10.1084/jem.150.1.1. View

Warren H . The generation of specific cytotoxic responses by human lymphocytes requires antigen and activities provided by a lymphokine supernatant. Scand J Immunol. 1981; 14(1):71-6. DOI: 10.1111/j.1365-3083.1981.tb00185.x. View

Morgan D, Ruscetti F, Gallo R . Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 1976; 193(4257):1007-8. DOI: 10.1126/science.181845. View

Lafferty K, Bootes A, Dart G, TALMAGE D . Effect of organ culture on the survival of thyroid allografts in mice. Transplantation. 1976; 22(2):138-49. DOI: 10.1097/00007890-197608000-00009. View

10.

TALMAGE D, Woolnough J, Hemmingsen H, Lopez L, Lafferty K . Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad Sci U S A. 1977; 74(10):4610-4. PMC: 431996. DOI: 10.1073/pnas.74.10.4610. View

11.

Simpson E, Mobraaten L, Chandler P, Hetherington C, Hurme M, Brunner C . Cross-reactive cytotoxic responses. H-2 restricted are more specific than anti-H-2 responses. J Exp Med. 1978; 148(6):1478-87. PMC: 2185100. DOI: 10.1084/jem.148.6.1478. View

12.

Andrus L, Lafferty K . Interleukin 2 production by alloantigen (H-2) activated T cells. Aust J Exp Biol Med Sci. 1981; 59(4):413-26. DOI: 10.1038/icb.1981.35. View